For Patients and Families For Healthcare Professionals

Are you a healthcare professional?

I am

Go back

Knopp Biosciences
  • Pipeline
  • Dexpramipexole
    • Market Landscape
  • Kv7 Platform
    • KCNQ2-EE Mutation
  • Knopp Biosciences
  • News & Resources
  • For Patients and Families
social-link social-link social-link
Inquire

News and Resources

Dexpramipexole Kv 7 Company News
  • All
  • Presentations
  • Publications
01.16.19

Knopp Biosciences Expands Research Collaboration with Cincinnati Children’s to Characterize Effect of Dexpramipexole in Inflammatory Diseases

Discover this News
09.08.18

Editorial Accompanying Blood Cover Story Features Promise Of Dexpramipexole In Eosinophil-Associated Diseases

Discover this News
08.04.18

American Society of Hematology: “Dexpramipexole: a new antieosinophil drug?”

Discover this News
05.22.18

NIAID Now: Repurposed Drug Shows Promise for Treating Rare Eosinophilic Diseases

Discover this News
05.10.18

Knopp Biosciences Announces Publication of Phase 2 Trial Results of Dexpramipexole in Hypereosinophilic Syndromes (HES) in Blood

Discover this News
01.01.18

American Society of Hematology: “Dexpramipexole as an oral steriod-sparing agent in hypereosinophilic syndromes”

Discover this News
01.01.18

The Laryngoscope: “Dexpramipexole Depletes Blood and Tissue Eosinophils in Nasal Polyps”

Discover this News
09.06.17

Knopp Biosciences and APFED Announce Partnership to Advance Awareness of Hypereosinophilic Syndromes

Discover this News
01.16.17

Elsevier: “The targeted eosinophil-lowering effects of dexpramipexole in clinical studies”

Discover this News
1 2
social-link social-link social-link

Learn More About the Unmet Needs We Strive to Address

Read Our Blog

Keep Up with Knopp, See What We Are Doing Next.




    Knopp Biosciences
    • Dexpramipexole
      • Market Landscape
    • Kv7 Platform
      • KCNQ2-EE Mutation
    • Pipeline
    • Knopp Biosciences
    • News & Resources
    Inquire +1 412-488-1776
    © Copyright 2021 Knopp Biosciences LLC. All Rights Reserved
    Privacy Policy Terms of Use
    social-link social-link social-link

    Knopp Disclaimer

    Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.